We used a xenograft mouse model, in which mice were challenged with Nalm-6 cells, to evaluate both the in vivo anti-tumor effects and safety of BAFF-R CRAFT-CAR T-cells (Figure 6A). This evidence concerns the gene TNFRSF13C and neoplasm.